| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 78, 898-903, Copyright © 1994 by Endocrine Society
ARTICLES |
H Wahrenberg, A Wennlund and P Arner
Department of Medicine, Huddinge University Hospital, Karolinska Institute, Sweden.
The influence of thyroid hormones on the adrenergic regulation of lipolysis was studied in isolated adipocytes removed from the gluteal region of hyper- and hypothyroid women and compared in adipocytes from euthyroid normal women. Noradrenaline significantly enhanced lipolysis in hyperthyroid patients, whereas noradrenaline inhibited lipolysis in hypothyroid patients compared to that in controls. Moreover, beta- adrenergic sensitivity and responsiveness were 10- and 2-fold increased, respectively, in hyperthyroid patients. In hypothyroid patients, beta-adrenoceptor responsiveness was reduced by 50%, whereas beta-adrenergic sensitivity remained unchanged compared with that in controls. Furthermore, the alpha 2-adrenergic and adenosine-induced antilipolytic effects were similar in all thyroid states. The lowered beta-adrenergic responsiveness seen in hypothyroidism could be mimicked by agents acting at the levels of phosphodiesterase (enprofylline), adenylate cyclase (forskolin) and protein kinase (dibutyryl cAMP). In hyperthyroidism, the increased beta-adrenergic sensitivity and responsiveness were not seen when lipolysis was stimulated at the adenylate cyclase, phosphodiesterase, or protein kinase levels. There was no change in the numbers of adipocyte beta- and alpha 2- adrenoceptors in hypothyroidism. However, the number of beta-adrenergic binding sites was doubled, whereas the fraction and affinities of isoprenaline high affinity sites remained unchanged in hyperthyroidism. Thus, the influence of thyroid hormone on catecholamine-stimulated lipolysis in man acts through different mechanisms when adipocytes are exposed to high or low levels of thyroid hormones. In hyperthyroidism, lipolysis adapts to increasing energy demands through an increase in the beta-adrenoceptor number and, thus, a more effective coupling of the adenylate-cyclase complex. In hypothyroidism, the low lipolytic effect of catecholamines seems to be mainly due to an impairment at the protein kinase level or to the hormone-sensitive lipase itself.
This article has been cited by other articles:
![]() |
J. Polak, C. Moro, E. Klimcakova, M. Kovacikova, M. Bajzova, M. Vitkova, Z. Kovacova, R. Sotornik, M. Berlan, N. Viguerie, et al. The atrial natriuretic peptide- and catecholamine-induced lipolysis and expression of related genes in adipose tissue in hypothyroid and hyperthyroid patients Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E246 - E251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M Villicev, F. R S Freitas, M. S Aoki, C. Taffarel, T. S Scanlan, A. S Moriscot, M. O Ribeiro, A. C Bianco, and C. H A Gouveia Thyroid hormone receptor {beta}-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats J. Endocrinol., April 1, 2007; 193(1): 21 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ortega, N. Pannacciulli, C. Bogardus, and J. Krakoff Plasma concentrations of free triiodothyronine predict weight change in euthyroid persons Am. J. Clinical Nutrition, February 1, 2007; 85(2): 440 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, D. B. Panagiotakos, E. Koukkou, M. Tzanela, N. Thalassinos, and S. A. Raptis Insulin Action in Adipose Tissue and Muscle in Hypothyroidism J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4930 - 4937. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Silva Thermogenic Mechanisms and Their Hormonal Regulation Physiol Rev, April 1, 2006; 86(2): 435 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, E. Koukkou, M. Tzanela, N. Thalassinos, and S. A. Raptis Glucose and Lipid Fluxes in the Adipose Tissue after Meal Ingestion in Hyperthyroidism J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1112 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. NEDVIDKOVA, M. HALUZIK, V. BARTAK, I. DOSTALOVA, P. VLCEK, P. RACEK, M. TAUS, M. BEHANOVA, S. SVACINA, S. ALESCI, et al. Changes of Noradrenergic Activity and Lipolysis in the Subcutaneous Abdominal Adipose Tissue of Hypo- and Hyperthyroid Patients: An In Vivo Microdialysis Study Ann. N.Y. Acad. Sci., June 1, 2004; 1018(1): 541 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Mariash Thyroid Hormone and the Adipocyte J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5603 - 5604. [Full Text] [PDF] |
||||
![]() |
M. Haluzik, J. Nedvidkova, V. Bartak, I. Dostalova, P. Vlcek, P. Racek, M. Taus, S. Svacina, S. Alesci, and K. Pacak Effects of Hypo- and Hyperthyroidism on Noradrenergic Activity and Glycerol Concentrations in Human Subcutaneous Abdominal Adipose Tissue Assessed with Microdialysis J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5605 - 5608. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Liu, J. J. Schultz, and G. A. Brent A Thyroid Hormone Receptor {alpha} Gene Mutation (P398H) Is Associated with Visceral Adiposity and Impaired Catecholamine-stimulated Lipolysis in Mice J. Biol. Chem., October 3, 2003; 278(40): 38913 - 38920. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Viguerie, L. Millet, S. Avizou, H. Vidal, D. Larrouy, and D. Langin Regulation of Human Adipocyte Gene Expression by Thyroid Hormone J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 630 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Lo, M.-M. Kau, Y.-H. Chen, S.-C. Tsai, Y.-C. Chiao, J.-J. Chen, C. Liaw, C.-C. Lu, B.-P. Lee, S.-C. Chen, et al. Acute effects of thyroid hormones on the production of adrenal cAMP and corticosterone in male rats Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E238 - E245. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hellstrom, H. Wahrenberg, S. Reynisdottir, and P. Arner Catecholamine-Induced Adipocyte Lipolysis in Human Hyperthyroidism J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 159 - 166. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |